You just read:

Indivior PLC Presents Results from the Phase 3 Pivotal Study of RBP-6000 Buprenorphine Monthly Depot for the Treatment of Opioid Use Disorder

News provided by

Indivior PLC

Jun 21, 2017, 12:24 ET